Moreover, the 36-month beta value for HQY is 0.81. Analysts have varying opinions on the stock, with 11 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The average price recommended by analysts for HealthEquity Inc. (HQY) is $82.23, which is $23.23 above the current market price. The public float for HQY is 82.87M and currently, short sellers hold a 3.61% of that float. On March 17, 2023, HQY’s average trading volume was 772.90K shares.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
HQY) stock’s latest price update
HealthEquity Inc. (NASDAQ: HQY)’s stock price has increased by 5.81 compared to its previous closing price of 55.76. Despite this, the company has seen a loss of -11.26% in its stock price over the last five trading days. The Wall Street Journal reported on 12/07/21 that Tesla, Intel, Bitcoin: What to Watch in the Stock Market Today
HQY’s Market Performance
HQY’s stock has fallen by -11.26% in the past week, with a monthly drop of -7.23% and a quarterly drop of -2.46%. The volatility ratio for the week is 9.06% while the volatility levels for the last 30 days are 4.13% for HealthEquity Inc. The simple moving average for the last 20 days is -7.89% for HQY stock, with a simple moving average of -8.22% for the last 200 days.
Analysts’ Opinion of HQY
Many brokerage firms have already submitted their reports for HQY stocks, with Goldman repeating the rating for HQY by listing it as a “Neutral.” The predicted price for HQY in the upcoming period, according to Goldman is $77 based on the research report published on October 21st of the previous year 2022.
KeyBanc Capital Markets, on the other hand, stated in their research note that they expect to see HQY reach a price target of $85. The rating they have provided for HQY stocks is “Overweight” according to the report published on September 16th, 2022.
Goldman gave a rating of “Sell” to HQY, setting the target price at $59 in the report published on July 12th of the previous year.
HQY Trading at -4.05% from the 50-Day Moving Average
After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.51% of loss for the given period.
Volatility was left at 4.13%, however, over the last 30 days, the volatility rate increased by 9.06%, as shares sank -10.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.80% lower at present.
During the last 5 trading sessions, HQY fell by -11.26%, which changed the moving average for the period of 200-days by -6.05% in comparison to the 20-day moving average, which settled at $63.72. In addition, HealthEquity Inc. saw -4.28% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at HQY starting from Wellborn Gayle Furgurson, who sale 5,237 shares at the price of $62.00 back on Dec 14. After this action, Wellborn Gayle Furgurson now owns 12,023 shares of HealthEquity Inc., valued at $324,694 using the latest closing price.
Ladd Delano, the EVP, GC & CORPORATE SECRETARY of HealthEquity Inc., sale 5,897 shares at $75.00 during a trade that took place back on Oct 21, which means that Ladd Delano is holding 37,471 shares at $442,275 based on the most recent closing price.
Stock Fundamentals for HQY
Current profitability levels for the company are sitting at:
- +5.36 for the present operating margin
- +45.06 for the gross margin
The net margin for HealthEquity Inc. stands at -5.85. Equity return is now at value -3.20, with -1.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.29.
To wrap up, the performance of HealthEquity Inc. (HQY) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.